Table 1. Baseline Characteristics of the Patients.
Characteristics | Patients, No. (%) | |
---|---|---|
TACE-RFA (n = 94) | RFA (n = 95) | |
Age, mean (SD), y | 53.3 (11.0) | 55.3 (13.3) |
Sex | ||
Men | 75 (80) | 71 (75) |
Women | 19 (20) | 24 (25) |
HBsAg | ||
Positive | 85 (90) | 83 (87) |
Negative | 9 (10) | 12 (13) |
HCV-Ab | ||
Positive | 6 (6) | 6 (6) |
Negative | 88 (94) | 89 (94) |
AFP, ng/mL | ||
<200 | 61 (65) | 64 (67) |
200-400 | 9 (10) | 11 (12) |
>400 | 24 (26) | 20 (21) |
No. of tumors | ||
1 | 62 (66) | 67 (71) |
2 | 21 (22) | 18 (19) |
3 | 11 (12) | 10 (11) |
Size of main tumor, mean (SD), cm | 3.47 (1.44) | 3.39 (1.35) |
Size range of tumor size, cm | ||
≤3 | 43 (46) | 46 (48) |
>3 | 51 (54) | 49 (52) |
GGT, mean (SD), U/L | 65.7 (30.3) | 68.4 (28.9) |
AST, mean (SD), U/L | 44.0 (29.3) | 42.0 (24.1) |
ALT, mean (SD), U/L | 35.0 (10.3) | 33.6 (9.7) |
TBIL, mean (SD), mg/dL | 0.79 (0.17) | 0.81 (0.19) |
PLT, mean (SD), × 103/μL | 121 (65) | 118 (64) |
PT, mean (SD), % | 77.6 (9.4) | 76.8 (10.1) |
ALB, g/dL | ||
<35 | 1.3 (1.4) | 1.5 (1.6) |
≥35 | 8.1 (8.6) | 8.0 (8.4) |
ICGR15 | ||
<10% | 72 (77) | 74 (78) |
10%-19.9% | 18 (19) | 17 (18) |
≥20% | 4 (4) | 4 (4) |
Child-Pugh class | ||
A | 90 (96) | 90 (95) |
B | 4 (4) | 5 (5) |
Ascites (yes/no) | ||
Yes | 6 (6) | 7 (7) |
No | 88 (94) | 88 (93) |
Abbreviations: AFP, α-fetoprotein; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, Ƴ-glutamyltransferase; HBsAg, hepatitis B surface antigen; HCV-Ab, hepatitis C virus antibody; ICGR15, indocyanine green retention rate in 15 minutes; PLT, platelet count; PT, prothrombin time; RFA, radiofrequency ablation; TBIL, total bilirubin; TACE, transcatheter arterial chemoembolization.
SI conversion factor: To convert AFP to μg/L, multiply by 1.0; GGT to μkat/L, multiply by 0.0167; AST to μkat/L, multiply by 0.0167; ALT to μkat/L, multiply by 0.0167; TBIL to μmol/L, multiply by 17.104; PLT to × 109/L, multiply by 1.0; ALB to g/L, multiply by 10.